BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23628324)

  • 21. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
    van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
    Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
    Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
    Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore.
    Gago-Dominguez M; Castelao JE; Sun CL; Van Den Berg D; Koh WP; Lee HP; Yu MC
    Carcinogenesis; 2004 Nov; 25(11):2143-7. PubMed ID: 15256483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes.
    Schnakenberg E; Fabig KR; Stanulla M; Strobl N; Lustig M; Fabig N; Schloot W
    Environ Health; 2007 Feb; 6():6. PubMed ID: 17291352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric carcinogenesis: Possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes.
    Tripathi S; Ghoshal U; Ghoshal UC; Mittal B; Krishnani N; Chourasia D; Agarwal AK; Singh K
    Scand J Gastroenterol; 2008; 43(4):431-9. PubMed ID: 18365908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population.
    V V; K V; Paul SF; P V
    Asian Pac J Cancer Prev; 2006; 7(2):325-8. PubMed ID: 16839232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.
    Zhong SL; Zhou SF; Chen X; Chan SY; Chan E; Ng KY; Duan W; Huang M
    Eur J Pharm Sci; 2006 May; 28(1-2):77-85. PubMed ID: 16488119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
    Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
    Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience].
    Bendjemana K; Abdennebi M; Gara S; Jmal A; Ghanem A; Touati S; Boussen H; Ladgham A; Guemira F
    Bull Cancer; 2006 Mar; 93(3):297-302. PubMed ID: 16567317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
    Hung HC; Chuang J; Chien YC; Chern HD; Chiang CP; Kuo YS; Hildesheim A; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):901-5. PubMed ID: 9367063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese.
    Darazy M; Balbaa M; Mugharbil A; Saeed H; Sidani H; Abdel-Razzak Z
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):423-9. PubMed ID: 21385088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.